Neuroscientists have just created an artificially intelligent algorithm that detects human brain activity and translates it into English sentences—and they said it was the first time such translations could be done on a 1:1 speed with natural human speech; faster-than-light.
#Repost “Some doctors are experimenting with adding nitric oxide to the mix, to help improve blood flow and oxygen to the least damaged parts of the lungs.”
Ironically enough nitric oxide improves blood oxygen flow, and also clears blood clots. Some patients who survive COVID19 have clots in the blood vessels in their lungs. We just have to wait and see.
(NEW YORK) — As health officials around the world push to get more ventilators to treat coronavirus patients, some doctors are moving away from using the breathing machines when they can. The reason: Some hospitals have reported unusually high death rates for coronavirus patients on ventilators, and some doctors worry that the machines could be harming certain patients.
Read more: Front Line Workers Tell Their Own Stories in the New Issue of TIME
Health hysteria has plagued the communications industry for decades despite the lack of evidence. 5G is no different.
A mutant bacterial enzyme that breaks down plastic bottles for recycling in hours has been created by scientists.
The enzyme, originally discovered in a compost heap of leaves, reduced the bottles to chemical building blocks that were then used to make high-quality new bottles. Existing recycling technologies usually produce plastic only good enough for clothing and carpets.
The company behind the breakthrough, Carbios, said it was aiming for industrial-scale recycling within five years. It has partnered with major companies including Pepsi and L’Oréal to accelerate development. Independent experts called the new enzyme a major advance.
Posted in biotech/medical, robotics/AI
Quarantine amid coronavirus could boost the nascent practice of seeking romance and friendship from artificial intelligence.
An early analysis of remdesivir, a drug developed by pharmaceutical firm Gilead, has shown that it may have improved severe symptoms of COVID-19 in 68% of patients after 18 days.
For the Gilead-funded study, doctors recruited 61 patients hospitalized with COVID-19 with oxygen saturation of 94% or less while breathing ambient air or receiving oxygen support. To receve remdesivir on a compassionate use basis (a program allowing the use of unapproved medicines when no other treatment options are available), on the first day of treatment, patients were administered 200mg of remesdevir, and then 100 mg daily on the remaining 9 days of treatment.
After 18 days of receiving the treatment, the doctors found just 53 patients who met the criteria following treatment for analysis. Among them, 36 (68%) had notable improvements in oxygen support class, including 17 patients receiving mechanical ventilation who were extubated. 25 patients were consequently discharged, while 7 died.
The FDA issued the emergency authorization to use blood purification devices to treat coronavirus patients on Friday.
Forced to stay at home amid the coronavirus pandemic, more residents of Christianburg, Virginia, are ordering from a pilot drone residential delivery service run by Google parent Alphabet. The most popular items: Coffee, toilet paper and cookies.
3D-printed ‘flexoskeletons’ make it possible to build a soft robot in less than two hours without extravagant costs.
Around a year ago…
Pretty cool.
In the past several months, China has offered several remote surgery demonstrations using 5G. The technologies promise better care over a wider area.
